TOP STORIES

• REGULATORY Nitrosamine Self-Inspection Deadline Extended to Aug. 1 amid Challenges
  August 1, 2024

• BUSINESS Sumitomo Announces Its Largest-Yet Job Cut of 700 Employees in Japan
  August 1, 2024

• REGULATORY Japan Aspires to Double Private Investments in Pharma Startups over 5 Years
  July 31, 2024

• BUSINESS Recordati Japan on Hunt for Rare Disease Assets at Risk of Drug Loss
  July 30, 2024

• BUSINESS Mitsubishi Tanabe to Launch Voluntary Buyout Program
  July 30, 2024

• BUSINESS EU Regulator Rejects Leqembi, Eisai to Seek Re-Examination
  July 29, 2024

• BUSINESS Takeda Will Stage Recovery at Home after 4 Drug Launches in FY2024: Japan Head
  July 26, 2024

• BUSINESS Global Pharma Market Grows Double Digit in 2023, Humira Stays Atop Drug Ranking: IQVIA
  July 26, 2024

• ORGANIZATION Japan Logs 10th Consecutive Year of Decrease in Drug Reps, Hefty Dip in 2023
  July 25, 2024

• BUSINESS Nichi-Iko to Join Forces with Kyowa in Generic Production, Eyeing Reorganization
  July 24, 2024

• REGULATORY LDP Policy Panel OKs FY2025 Budget Guidelines, Lower Cap Likely for “Natural Increase”
  July 24, 2024

• BUSINESS Axcelead-Teijin JV Anticipates Synergies in Common Disease Areas, Pipelines
  July 23, 2024

• BUSINESS Terumo to End Sale of HeartSheet after Panel’s Thumbs-Down
  July 22, 2024

• REGULATORY Japan Panel Says No to Full Approval of HeartSheet, Clears Breyanzi’s Broader Label
  July 22, 2024

• REGULATORY MHLW Pharma Management Director Hints at Addressing “Zero” Premium Issue
  July 19, 2024

• REGULATORY Debates on FY2025 Off-Year Price Revision Officially Set Sail at Chuikyo
  July 18, 2024

• BUSINESS Insmed Set to Double Japan Staff by 2025-End as It Gears Up for Brensocatib Debut
  July 17, 2024

• BUSINESS LTL, Cheplapharm Envision Heightened Opportunities for LLP Takeovers under Elective Care Scheme
  July 16, 2024

• BUSINESS Meiji Paints Consortium Plan of Its Own, Woos Generic Peers to Join Scheme
  July 16, 2024

• BUSINESS Chiesi Joins Japan Rare Disease Market, Shoots for 10 Billion Yen Sales by 2030
  July 12, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• …
• Next ›
• 最終 »